NLRP3 and dilated cardiomyopathy: A significant activation of NLRP3 in the myocardium and increased expression of caspase-1, IL-1β, and IL-18 in patients with end-stage HF due to dilated cardiomyopathy indicates the role of pyroptosis in HF [73].